ArticleTranslational lung cancer research2022

SP142 evaluation contributes to the prediction of immune checkpoint inhibitor efficacy in non-small cell lung cancer with high PD-L1 expression assessed by 22C3.

Kenji Nakahama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.